Cardiovascular risk factors are not treated to target in hypertensive patients in primary care

Blood Pressure

Volumn 19, Issue 3, 2010, Pages 176-181

  Nieburg, Ingegerd ^a   Kahan, Thomas ^b  

^a Stocksund Primary Health Care Centre   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

Age; Gender; Hypertension; Primary healthcare; Risk assessment; Risk factor

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; AWARENESS; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; ELECTRONIC MEDICAL RECORD; EXERCISE; FAMILY HISTORY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MICROALBUMINURIA; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; SWEDEN;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; LIPIDS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SWEDEN;

EID: 77952806962     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2010.483053     Document Type: Article

References (20)

1. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347-1360.
2. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187.
3. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfi eld MJ, et al. Reappraisal of European guidelines of hypertension management: A European Society of Hypertension Task Force document. J Hypertens. 2009;27:2121-2159.
4. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: Full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007;14 Suppl 2:S1-S113.
5. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care. 2009;32 Suppl 1:13-61.
6. Lindholm, LH, Agenäs I, Carlbeg B, Dahlgren H, de Faire U, Hedblad B, et al. Moderately elevated blood pressure. A systematic literature review. Stockholm: The Swedish Council on Technology Assessment in Health Care. 2004. Report 170/1, 1-248 and 170/2, 1-514.
7. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363-2369.
8. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008;52:818-827.
9. Weinehall L, Ohgren B, Persson M, Stegmayr B, Boman K, Hallmans G, et al. High remaining risk in poorly treated hypertension: The 'rule of halves' still exists. J Hypertens. 2002;20:2081-2088.
10. Hedblad B, Nerbrand C, Ekesbo R, Johansson L, Midlöv P, Brunkstedt I, et al. High blood pressure despite treatment: Results from a cross-sectional primary healthcare-based study in southern Sweden. Scand J Prim Health Care. 2006; 24:224-230.
11. Journath G, Hellénius ML, Petersson U, Theobald H, Nilsson PM; Hyper-Q Study Group Sweden. Sex differences in risk factor control of treated hypertensives: A national primary healthcare-based study in Sweden. Eur J Cardiovasc Prev Rehabil. 2008;15:258-262.
12. Fagard RH, van den Enden M, Leeman M, Warling X. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratifi cation in primary care in Belgium. J Hypertens. 2002;20:1297-1302.
13. Buckley B, Shanahan E, Colwell N, Turgonyi E, Bramlage P, Perry IJ. Blood pressure control in hypertensive patients in Irish primary care practices. J Clin Hypertens (Greenwich). 2009;11:432-440.
14. Law MR, Morris,JK, Wald NJ, Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:1245-1252.
15. Ljungman C, Mortensen L, Kahan T, Manhem K. Treatment of mild to moderate hypertension by gender perspective. J Womens Health. 2009;18:1049-1062.
16. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfi eld M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo- Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial. Lancet. 2003;361:1149-1158. (Pubitemid 36398384)
17. Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, et al. Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: An economic analysis of the Anglo- Scandinavian Cardiac Outcomes Trial-lipid-lowering arm (ASCOT-LLA). Eur J Cardiovasc Prev Rehabil. 2005;12:29-36.
18. Fahey T, Schroeder K, Ebrahim S. Educational and organisational interventions used to improve the management of hypertension in primary care: A systematic review. Br J Gen Pract. 2005;55:875-882.
19. Walsh JM, McDonald KM, Shojania KG, Sundaram V, Nayak S, Lewis R, et al. Quality improvement strategies for hypertension management: A systematic review. Med Care. 2006;44:646-657.
20. Eliasson B, Cederholm J, Nilsson P, Gudbjörnsdóttir S. The gap between guidelines and reality: Type 2 diabetes in a National Diabetes Register 1996-2003. Diabet Med.2005;22: 1420-1426.